Axcelis Technologies Breaks Out As Shares Zip Higher; 20% Growth Expected, But There's This Flaw
Axcelis Technologies Breaks Out As Shares Zip Higher; 20% Growth Expected, But There's This Flaw
Axcelis Technologies took off following its recent earnings report in early May, hitting a buy point of a base on Wednesday, and is the IBD 50 Stocks To Watch pick.
Axcelis 科技 继5月初发布最近的财报后起飞，周三触及基本买入点，是IBD 50只值得关注的股票精选。
The Beverly, Mass.-based company provides spare parts, equipment upgrades and maintenance services to the semiconductor industry.
马萨诸塞州贝弗利酒店总部位于美国的公司为半导体行业提供备件、设备升级和维护服务。
More specifically, Axcelis Technologies produces ion implantation equipment used in the fabrication of semiconductor chips. Its products are developed and manufactured mainly in the U.S. and South Korea, and are sold in the U.S., Europe and Asia.
更具体地说，Axcelis Technologies生产用于制造半导体芯片的离子注入设备。其产品主要在美国和韩国开发和制造，并在美国、欧洲和亚洲销售。
A high 64.7% of its March quarter revenues came from its 10 largest customers. If several big customers were to leave, it could be a revenue-impacting event.
其3月季度收入的64.7％来自其十大客户。如果有几个大客户离开，那可能会影响收入。
Axcelis Technologies holds the No. 2 spot out of 29 stocks in the Electronics-Semiconductor Equipment group. The group ranks 42nd out of the 197 IBD industry groups.
在电子半导体设备集团的29只股票中，Axcelis Technologies排名第二。该集团在 197 个 IBD 行业集团中排名第 42 位。
The CAN SLIM investing strategy seeks stocks in the top 40 or higher industry groups.
CAN SLIM投资策略寻找排名前40或以上的行业群体的股票。
Axcelis Technologies Breaks Out Of Base
Accelis科技突破了困境
Shares jumped another 4% Thursday following Wednesday's spike, as tech stocks continued to rally. Shares Thursday afternoon were slightly above the 5% buy zone, which tops out at 143.30.
由于科技股继续上涨，周三股价飙升后，周四又上涨了4％。周四下午股价略高于5％的买入区域，最高为143.30。
ACLS popped 6% and broke out of a cup-without-handle base on Wednesday, hitting the 136.48 buy point. Although price action was strong, volume was only about average.
周三，ACLS上涨了6％，突破了无把手的杯赛基础，触及136.48的买入点。尽管价格走势强劲，但成交量仅为平均水平。
The formation is in a desirable second-stage base, according to MarketSmith pattern recognition.
根据MarketSmith模式识别，该阵型处于理想的第二阶段基础。
The relative strength line hit a 52-week high, as shown with the blue dot on the weekly MarketSmith chart. Shares hit an all-time high Thursday, and have gained over 80% this year so far.
相对强弱线触及52周高点，如每周MarketSmith图表上的蓝点所示。周四股价创下历史新高，今年迄今已上涨80％以上。
The stock hit the low of the base on May 4, following volatile trading that greeted the Q1 earnings report. Results topped expectations, but the company's outlook was cautious.
在迎接第一季度财报的波动之后，该股于5月4日触及基数的低点。业绩超出预期，但该公司的前景持谨慎态度。
The stock quickly reversed course the next day, and has been on an upward trajectory ever since. Shares have gained over 25% since the earnings release.
第二天，该股迅速逆转，此后一直处于上涨轨道。自财报发布以来，股价已上涨了25％以上。
ACLS reclaimed the key 50-day moving average this week, as chip and tech stocks outperformed.
由于芯片和科技股跑赢大盘，ACLS本周收复了关键的50天移动平均线。
Earnings Beat Projections But Pace Slows
收益超出预期，但步伐放缓
Axcelis Technologies reported better-than-expected first quarter EPS and sales on May 3, after the market close. The 17% quarterly profit growth lagged the 63% and 49% growth in the prior two quarters, and triple-digit increases prior to that.
市场收盘后，Axcelis Technologies于5月3日公布的第一季度每股收益和销售额好于预期。17％的季度利润增长落后于前两个季度的63％和49％的增长，在此之前则实现了三位数的增长。
Quarterly sales growth of 25% slowed from the 29% and 30% the prior two quarters.
25％的季度销售增长从前两个季度的29％和30％放缓。
"Axcelis delivered strong first quarter financial performance with a new backlog record, as a result of significant demand and solid execution by the Axcelis team," said Mary Puma, president and CEO.
总裁兼首席执行官Mary Puma表示：“由于Axcelis团队的巨大需求和稳健的执行力，Axcelis在第一季度取得了强劲的财务业绩，创下了新的积压记录。”
Management expects revenues between $255 million and $260 million, with full-year sales of more than $1.03 billion.
管理层预计收入在2.55亿美元至2.6亿美元之间，全年销售额超过10.3亿美元。
Q1 gross margin rate fell to 40.9% from 44.1% in the same quarter a year earlier. The drop came primarily from a less favorable mix of system shipments.
第一季度毛利率从去年同期的44.1％降至40.9％。下降的主要原因是系统出货量组合不太乐观。
Management projects 42% gross margin for Q2, and 44% for full-year 2023, up slightly from the 43.7% in 2022.
管理层预计第二季度的毛利率为42％，2023年全年为44％，略高于2022年的43.7％。
Analysts expect 20% full-year earnings growth this year, and 17% next year; that's on top of the nearly 90% growth in 2022.
分析师预计，今年全年收益将增长20％，明年将增长17％；这是在2022年近90％的增长基础上进行的。
Mutual Funds Support Stock; ACLS Earns Accolades
共同基金支持股票；ACLS 获得赞誉
Mutual funds own 58% of shares, with 573 holding the stock in March, up from 515 in December.
共同基金拥有58％的股份，3月份有573人持有该股，高于12月的515份。
Two funds in the IBD Mutual Fund Index increased their holdings in ACLS shares in the March quarter. Columbia Small-Cap Index/Institutional (CXXRX) added 280,000 shares, and it is a top holding. Invesco Discovery Fund A (OPOCX) added 260,000 shares.
IBD共同基金指数中的两只基金在3月份的季度增加了对ACLS股票的持有量。哥伦比亚小盘股指数/机构（CXXRX）增加了28万股，是头号持股。景顺探索基金A（OPOCX）增加了26万股。
Axcelis Technologies earned a place on the 2022 Fortune 100 Fastest Growing Companies. In addition, it landed on the 2022 Forbes Best Mid-Size Companies list.
Axcelis Technologies在2022年财富100强增长最快的公司中获得了一席之地此外，它还登上了2022年福布斯最佳中型公司名单。
Follow Kimberley Koenig for more stock news on Twitter @IBD_KKoenig.
在 Twitter 上关注 Kimberley Koenig 了解更多股票新闻 @IBD_KKoenig。
YOU MAY ALSO LIKE:
你可能还喜欢：
Get Free IBD Newsletters: Market Prep | Tech Report | How To Invest
免费获取 IBD 时事通讯：市场准备 | 技术报告 | 如何投资
What Is CAN SLIM? If You Want To Find Winning Stocks, Better Know It
什么是 CAN SLIM？如果你想找到获胜的股票，最好知道了
IBD Live: Learn And Analyze Growth Stocks With The Pros
IBD Live：与专业人士一起学习和分析成长型股票
Looking For The Next Big Stock Market Winners? Start With These 3 Steps
寻找下一个股市大赢家？从这 3 个步骤开始
Want More IBD Insights? Subscribe To Our Investing Podcast
想了解更多 IBD 见解吗？订阅我们的投资播客
译文内容由第三方软件翻译。